Key result
miR-191 mimics inhibit Myog and differentiation markers by directly targeting the Wwp1 gene.
Why the study?
The mechanisms by which diseases such as COPD and cancer affect skeletal muscle metabolism need to be deeply explored.
The miR-191/Wwp1 axis plays an important role in skeletal muscle differentiation, providing a potential therapeutic target for muscle atrophy induced by COPD and cancer cachexia.
No immediate clinical implications for muscle wasting; leaves open miR-191 targeting after human validation.
Skeletal muscle atrophy is a key complication of various diseases, such as chronic obstructive pulmonary disease (COPD) and cancer. The mechanisms by which these diseases affect skeletal muscle metabolism need to be deeply explored. By analyzing the miRNA expression profiles in the plasma of patients with COPD, we found that miR-191 expression was significantly altered and it may influence skeletal muscle metabolism by regulating ubiquitination and the mTOR pathway. Using a mouse model of skeletal muscle injury induced by cardiotoxin, we found that miR-191 and Wwp1 showed a dynamic negative correlation in injury repair. Transfection with miR-191 mimics significantly inhibited the expression of myogenic regulatory factor Myog and differentiation markers Myh1/7/8, while downregulating key genes in the mTOR pathway. Molecular mechanism studies showed that miR-191 could directly act on the 3’ untranslated region of the Wwp1 gene to inhibit its expression. This study reveals the important role of the miR-191/Wwp1 axis in skeletal muscle differentiation and provides a novel theoretical basis for research on muscle atrophy induced by COPD, cancer cachexia, and other diseases.
No takes yet. Share an insight, caveat, or question.
Pu et al. (2026) studied Skeletal muscle atrophy. miR-191 mimics was evaluated on Expression of myogenic regulatory factor Myog and differentiation markers. Transfection with miR-191 mimics significantly inhibited the expression of myogenic regulatory factor Myog and differentiation markers by directly targeting the Wwp1 gene.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: